HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong-Seok Kim Selected Research

2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- one

8/2017Dual hypopigmentary effects of punicalagin via the ERK and Akt pathways.
6/2014KHG26792 Inhibits Melanin Synthesis in Mel-Ab Cells and a Skin Equivalent Model.
8/2012PP2A and DUSP6 are involved in sphingosylphosphorylcholine-induced hypopigmentation.
5/2010Hypopigmentary action of dihydropyranocoumarin D2, a decursin derivative, as a MITF-degrading agent.
4/2006Sphingosylphosphorylcholine-induced ERK activation inhibits melanin synthesis in human melanocytes.
8/2005Heat treatment decreases melanin synthesis via protein phosphatase 2A inactivation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong-Seok Kim Research Topics

Disease

28Neoplasms (Cancer)
01/2022 - 01/2004
16Glioma (Gliomas)
08/2020 - 10/2008
15Melanoma (Melanoma, Malignant)
01/2018 - 01/2004
9Hypopigmentation (Hypomelanosis)
08/2017 - 08/2005
8Germinoma
01/2022 - 04/2009
7Epilepsy (Aura)
05/2019 - 04/2008
6Moyamoya Disease (Moya-Moya Disease)
10/2014 - 01/2011
6Brain Neoplasms (Brain Tumor)
10/2013 - 03/2004
5Inflammation (Inflammations)
09/2021 - 04/2004
5Medulloblastoma
01/2018 - 03/2004
3Wounds and Injuries (Trauma)
01/2022 - 04/2003
3Neoplasm Metastasis (Metastasis)
04/2021 - 04/2010
3Vitiligo
08/2014 - 11/2005
3Carcinoma (Carcinomatosis)
04/2011 - 02/2010
3Experimental Melanoma
04/2010 - 01/2007
2Atopic Dermatitis (Atopic Eczema)
08/2020 - 05/2013
2Hydrocephalus (Hydrocephaly)
03/2020 - 04/2008
2Drug Resistant Epilepsy
10/2019 - 05/2019
2Seizures (Absence Seizure)
01/2019 - 04/2015
2Rhabdoid Tumor (Rhabdoid Tumors)
12/2017 - 08/2013
2Skin Diseases (Skin Disease)
08/2015 - 03/2014
2Hyperpigmentation
08/2015 - 01/2015
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2014 - 11/2012
2Astrocytoma (Pilocytic Astrocytoma)
10/2013 - 03/2004
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2011 - 04/2011
2Chronic Disease (Chronic Diseases)
03/2011 - 10/2010
2Prostatic Neoplasms (Prostate Cancer)
01/2011 - 11/2010
1Ulcer
09/2021
1Enteritis
09/2021
1Neurologic Manifestations (Neurological Manifestations)
03/2020
1Ependymoma
03/2020
1Muscle Hypotonia (Hypotonia)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2019
1Partial Epilepsies (Epilepsy, Partial)
12/2018
1Weight Gain
10/2018
1Hyperlipidemias (Hyperlipidemia)
10/2018
1Chordoma
02/2018
1Second Primary Neoplasms (Neoplasms, Second)
01/2018
1Infections
01/2018
1Normal Pressure Hydrocephalus
01/2018
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Syncope (Fainting)
11/2016

Drug/Important Bio-Agent (IBA)

13Leucine (L-Leucine)FDA Link
08/2020 - 10/2008
8Proteins (Proteins, Gene)FDA Link
01/2018 - 03/2004
8indoleacetic acid (indole acetic acid)IBA
11/2010 - 01/2004
7Horseradish PeroxidaseIBA
02/2010 - 01/2004
6CytokinesIBA
09/2021 - 07/2013
62- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
08/2017 - 08/2005
4beta CateninIBA
05/2014 - 04/2010
4Free RadicalsIBA
11/2010 - 01/2004
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2019 - 06/2014
3Melanins (Melanin)IBA
02/2014 - 03/2004
3Death Domain ReceptorsIBA
02/2010 - 01/2004
2LipopolysaccharidesIBA
01/2021 - 11/2018
2Polysaccharides (Glycans)IBA
12/2018 - 05/2013
2NestinIBA
10/2017 - 12/2013
22- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
08/2017 - 07/2013
2AdiponectinIBA
07/2017 - 05/2013
2AdipokinesIBA
07/2017 - 06/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2017 - 04/2015
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2015 - 06/2014
2Melanocyte-Stimulating Hormones (MSH)IBA
02/2014 - 11/2012
2Biological ProductsIBA
05/2013 - 01/2013
2alpha-MSHIBA
03/2013 - 01/2007
2sphingosine phosphorylcholineIBA
08/2012 - 08/2011
2Proteasome InhibitorsIBA
05/2010 - 04/2010
2benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
05/2010 - 04/2010
1Small Interfering RNA (siRNA)IBA
01/2022
1DA 9601IBA
09/2021
1aceclofenacIBA
09/2021
1Tumor Biomarkers (Tumor Markers)IBA
11/2020
1Peptides (Polypeptides)IBA
08/2020
1SolutionsIBA
01/2020
1Eukaryotic Initiation Factor-4EIBA
10/2019
1Metformin (Glucophage)FDA LinkGeneric
10/2019
1Pharmaceutical PreparationsIBA
01/2019
1mitomycin C-dextranIBA
12/2018
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2018
1LipidsIBA
10/2018
1Triglycerides (Triacylglycerol)IBA
10/2018
1Brachyury protein (Brachyury)IBA
02/2018
1Amino AcidsFDA Link
01/2018
1SynaptophysinIBA
10/2017
1Oligodendrocyte Transcription Factor 2IBA
10/2017
1punicalaginIBA
08/2017
1Terpenes (Terpenoids)IBA
08/2016

Therapy/Procedure

14Radiotherapy
11/2020 - 04/2009
12Therapeutics
05/2019 - 01/2004
9Drug Therapy (Chemotherapy)
01/2022 - 06/2007
7Craniospinal Irradiation
11/2020 - 03/2008
3Ventriculostomy
01/2018 - 06/2007
2Aftercare (After-Treatment)
09/2021 - 01/2018
2Sutures (Suture)
01/2018 - 05/2016
2Craniotomy
11/2009 - 04/2009
2Electrodes (Electrode)
05/2009 - 04/2008
1Adjuvant Radiotherapy
04/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2020
1Neurosurgical Procedures
01/2018
1Surgical Decompression
11/2016